文献速递儿童内分泌与遗传代谢

智利新冠疫情期间儿童1型糖尿病发病率与严重程度分析

Incidence and Severity of Type 1 Diabetes in Children Through the COVID-19 Pandemic in Chile.
PubMed 文献 · Pediatrics · 2026-01-01

该研究基于智利全国登记(2007-2023)分析20岁以下1型糖尿病发病率,并比较3家三级中心(2016-2023)18岁以下患者糖尿病酮症酸中毒比例。

要点

  • 智利20岁以下1型糖尿病发病率从2007年7.4例/10万人升至2023年13.9例/10万人。
  • 2020-2021年实际季度发病率显著高于SARIMA模型预测,2022-2023年无显著差异。

核心结论

  • 新冠疫情期间智利20岁以下人群1型糖尿病发病率显著增加,且起病时DKA比例更高,之后恢复至疫情前趋势。

研究设计与样本

  • 基于全国登记(2007-2023)的20岁以下1型糖尿病发病率人群分析,共纳入9583人。
  • 对3家三级中心(2016-2023)18岁以下1型糖尿病患者进行个体前后分析,共334例。

主要发现

  • 1型糖尿病发病率从2007年7.4例/10万人升至2023年13.9例/10万人(20岁以下人群)。
  • 10-14岁年龄组和冬季的平均发病率显著更高。
  • 2020-2021年实际季度发病率显著高于SARIMA预测值,2022-2023年无显著差异。

关键数值与推荐

  • 1型糖尿病发病率:2007年7.4例/10万人,2023年13.9例/10万人(20岁以下人群)。

临床怎么用

  • 儿科医生在疫情期间及之后需警惕1型糖尿病起病时DKA风险升高,尽早识别并转诊。
  • 对10-14岁儿童及冬季高发时段加强1型糖尿病症状宣教和筛查意识。

局限性

  • 原文未报告SARIMA模型的具体参数和预测区间。
  • DKA分析仅来自3家三级中心,可能不代表全国情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: An increase in type 1 diabetes (T1D) incidence and severity was reported worldwide during the COVID-19 pandemic. The objective is to analyze whether this also occurred in the Chilean population aged less than 20 years. METHODS: A population-based analysis was performed with people aged less than 20 years with T1D from a nationwide registry (2007-2023). Annual and quarterly incidence rates were calculated. Incidence rate ratios were used to compare averages by sex, age groups, and season. A seasonal autoregressive integrated moving average (SARIMA) model was used to predict incidence rates from 2020, comparing them with actual rates. An individual pre-post analysis was also performed with patients aged less than 18 years with T1D from 3 tertiary centers (2016-2023). Diabetic ketoacidosis (DKA) proportions were compared with Fisher's exact test between 2016-2019 and 2020-2023. RESULTS: This study included 9583 individuals. T1D incidence increased from 7.4 cases in 2007 to 13.9 cases in a population of 100 000 aged less than 20 years in 2023. Average incidence rates were significantly higher in the 10- to 14-year age group and in winter. Actual quarterly rates were significantly higher than those SARIMA predicted from 2020 to 2021 and not significantly different from 2022 to 2023. Of 334 patients, 71% had DKA. A significant increase in DKA from 64.3% to 75.9% was found in 2020-2023 (P = .03). CONCLUSIONS: This study includes relevant data after 2021 and regarding severity. A significant increase in T1D incidence was found during the COVID-19 pandemic, paired with a higher severity at onset, returning to the prepandemic trend afterward. A causal relationship may be argued.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Kutz C, Alarcón-Andrade G, Aguilera E, et al. Incidence and Severity of Type 1 Diabetes in Children Through the COVID-19 Pandemic in Chile. Pediatrics. 2026. PMID: 42019952. doi:10.1542/peds.2025-072191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。